EBMT Study Links Graft Source to MF Engraftment

An EBMT registry analysis of 263 myelofibrosis patients undergoing haploidentical HCT reported primary graft failure in 12% of marrow versus 4% of peripheral-blood graft recipients. Higher peripheral-blood CD34+ dose correlated with faster neutrophil recovery,…













